Higèa S.p.A., a company controlled by Althea (formerly Pantheon Healthcare Group), has finalised the acquisition of the 80% of Biomedicale S.r.l., a company owned by Zephyro S.p.A., an Italian company listed at AIM market of “Borsa Italiana” and operating in the healthcare and facility management industries.
With this important operation, Higèa S.p.A., that counts more than 400 employees, a turnover of approx. 100 Millions of Euro and a portfolio with more than 100 Italian and European health facilities, consolidates its leadership in the healthcare engineering services.
This acquisition has a key role in the development process of Althea (formerly Pantheon Healthcare Group), which includes, besides Higèa, other companies such as Asteral, MESA, Ed Sloan & Associates, Sigil, Spintech and MVS.
The Group, founded in August 2014, is at its thirteenth acquisition conducted in several countries, with a focus in European market.
Alessandro Dogliani, Group CEO declares, “An operation in line with the strategies for the growth of Higèa and Althea that will allow us to strengthen our biomedical integrated services, and, thanks to our know-how, to develop the management processes, improving the results”.
This operation, performed a few weeks after the acquisition of Iteon Tecnologie S.r.l. biomedical division, was achieved with the support of Ernst & Young, Giliberti Pappalettera e Triscornia and Maisto e Associati.